Tag: TAS-102

Racial differences in colorectal cancer survival linked to health at initial diagnosis

Trifluridine–Tipiracil and Bevacizumab Improves Survival in Metastatic Pretreated Colorectal Cancer

byDaniel Goldshteinand1 others

May 15, 2023

1. The median overall survival was 10.8 months in the combination group (FTD–TPI + bevacizumab) and 7.5 months in the ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Radiotherapy and abiraterone improve survival in low-volume metastatic castration-sensitive prostate cancer
Use of hydroxychloroquine may be protective for cardiovascular events in patients with systemic lupus erythematosus
#VisualAbstract: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

No Result

View All Result